Is RDNT or INNV more profitable?

InnovAge has a net margin of -0.26% compared to RadNet's net margin of -0.93%. RadNet's return on equity of 2.61% beat InnovAge's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.93% 2.61% 0.91% InnovAge -0.26% -1.03% -0.47%

Does the media refer more to RDNT or INNV?

In the previous week, InnovAge had 6 more articles in the media than RadNet. MarketBeat recorded 12 mentions for InnovAge and 6 mentions for RadNet. RadNet's average media sentiment score of 0.26 beat InnovAge's score of 0.25 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InnovAge 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to INNV or BLLN?

In the previous week, InnovAge and InnovAge both had 12 articles in the media. Billiontoone's average media sentiment score of 0.27 beat InnovAge's score of 0.25 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Billiontoone 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer INNV or LFST?

In the previous week, InnovAge had 8 more articles in the media than LifeStance Health Group. MarketBeat recorded 12 mentions for InnovAge and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.72 beat InnovAge's score of 0.25 indicating that LifeStance Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral LifeStance Health Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRVL or INNV?

InnovAge has a consensus price target of $10.50, indicating a potential upside of 18.78%. Given InnovAge's higher probable upside, analysts clearly believe InnovAge is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 InnovAge 2 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75

Which has better valuation & earnings, CRVL or INNV?

CorVel has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.92 $110.34M $2.25 32.77 InnovAge $989.71M 1.22 -$2.54M -$0.02 N/A

Is CRVL or INNV more profitable?

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -0.26%. CorVel's return on equity of 29.92% beat InnovAge's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.72% 29.92% 17.82% InnovAge -0.26% -1.03% -0.47%

Does the media refer more to CRVL or INNV?

In the previous week, InnovAge had 5 more articles in the media than CorVel. MarketBeat recorded 12 mentions for InnovAge and 7 mentions for CorVel. CorVel's average media sentiment score of 0.79 beat InnovAge's score of 0.25 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor INNV or OPCH?

In the previous week, InnovAge had 8 more articles in the media than Option Care Health. MarketBeat recorded 12 mentions for InnovAge and 4 mentions for Option Care Health. Option Care Health's average media sentiment score of 0.55 beat InnovAge's score of 0.25 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Option Care Health 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

InnovAge (INNV) Competitors

$8.84 -0.16 (-1.78%)

Closing price 04:00 PM Eastern

Extended Trading

$8.83 -0.01 (-0.11%)

As of 07:30 PM Eastern

Compare

INNV vs. RDNT, BLLN, LFST, CRVL, and OPCH

Should you buy InnovAge stock or one of its competitors? InnovAge's main competitors and comparable companies include RadNet (RDNT), Billiontoone (BLLN), LifeStance Health Group (LFST), CorVel (CRVL), and Option Care Health (OPCH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does InnovAge compare to RadNet?

RadNet (NASDAQ:RDNT) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

InnovAge has lower revenue, but higher earnings than RadNet. InnovAge is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.75	-$18.65M	-$0.27	N/A
InnovAge	$989.71M	1.22	-$2.54M	-$0.02	N/A

77.9% of RadNet shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 1.0% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 26.21%. InnovAge has a consensus price target of $10.50, suggesting a potential upside of 18.78%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts plainly believe RadNet is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

InnovAge has a net margin of -0.26% compared to RadNet's net margin of -0.93%. RadNet's return on equity of 2.61% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
InnovAge	-0.26%	-1.03%	-0.47%

In the previous week, InnovAge had 6 more articles in the media than RadNet. MarketBeat recorded 12 mentions for InnovAge and 6 mentions for RadNet. RadNet's average media sentiment score of 0.26 beat InnovAge's score of 0.25 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InnovAge	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market.

Summary

RadNet beats InnovAge on 13 of the 17 factors compared between the two stocks.

How does InnovAge compare to Billiontoone?

InnovAge (NASDAQ:INNV) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

Billiontoone has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$989.71M	1.22	-$2.54M	-$0.02	N/A
Billiontoone	$305.11M	19.32	$7.45M	$0.70	178.43

InnovAge currently has a consensus price target of $10.50, suggesting a potential upside of 18.78%. Billiontoone has a consensus price target of $125.88, suggesting a potential upside of 0.78%. Given InnovAge's higher probable upside, analysts plainly believe InnovAge is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Billiontoone	2 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.45

Billiontoone has a net margin of 8.04% compared to InnovAge's net margin of -0.26%. Billiontoone's return on equity of 9.96% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-0.26%	-1.03%	-0.47%
Billiontoone	8.04%	9.96%	5.35%

12.3% of InnovAge shares are held by institutional investors. 1.0% of InnovAge shares are held by insiders. Comparatively, 50.2% of Billiontoone shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, InnovAge and InnovAge both had 12 articles in the media. Billiontoone's average media sentiment score of 0.27 beat InnovAge's score of 0.25 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Billiontoone	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Billiontoone beats InnovAge on 11 of the 14 factors compared between the two stocks.

How does InnovAge compare to LifeStance Health Group?

InnovAge (NASDAQ:INNV) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

InnovAge presently has a consensus target price of $10.50, suggesting a potential upside of 18.78%. LifeStance Health Group has a consensus target price of $12.88, suggesting a potential upside of 9.11%. Given InnovAge's higher possible upside, analysts clearly believe InnovAge is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

InnovAge has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 1.0% of InnovAge shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LifeStance Health Group has a net margin of 3.19% compared to InnovAge's net margin of -0.26%. LifeStance Health Group's return on equity of 3.39% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-0.26%	-1.03%	-0.47%
LifeStance Health Group	3.19%	3.39%	2.33%

LifeStance Health Group has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$989.71M	1.22	-$2.54M	-$0.02	N/A
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	90.77

In the previous week, InnovAge had 8 more articles in the media than LifeStance Health Group. MarketBeat recorded 12 mentions for InnovAge and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.72 beat InnovAge's score of 0.25 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeStance Health Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LifeStance Health Group beats InnovAge on 15 of the 17 factors compared between the two stocks.

How does InnovAge compare to CorVel?

CorVel (NASDAQ:CRVL) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

CorVel has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.92	$110.34M	$2.25	32.77
InnovAge	$989.71M	1.22	-$2.54M	-$0.02	N/A

CorVel has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

51.4% of CorVel shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 39.7% of CorVel shares are owned by company insiders. Comparatively, 1.0% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -0.26%. CorVel's return on equity of 29.92% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.72%	29.92%	17.82%
InnovAge	-0.26%	-1.03%	-0.47%

InnovAge has a consensus price target of $10.50, indicating a potential upside of 18.78%. Given InnovAge's higher probable upside, analysts clearly believe InnovAge is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

In the previous week, InnovAge had 5 more articles in the media than CorVel. MarketBeat recorded 12 mentions for InnovAge and 7 mentions for CorVel. CorVel's average media sentiment score of 0.79 beat InnovAge's score of 0.25 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CorVel beats InnovAge on 12 of the 16 factors compared between the two stocks.

How does InnovAge compare to Option Care Health?

InnovAge (NASDAQ:INNV) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 1.0% of InnovAge shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, InnovAge had 8 more articles in the media than Option Care Health. MarketBeat recorded 12 mentions for InnovAge and 4 mentions for Option Care Health. Option Care Health's average media sentiment score of 0.55 beat InnovAge's score of 0.25 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Option Care Health	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

InnovAge has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, Option Care Health has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

InnovAge presently has a consensus target price of $10.50, suggesting a potential upside of 18.78%. Option Care Health has a consensus target price of $29.92, suggesting a potential upside of 30.44%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Option Care Health	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Option Care Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$989.71M	1.22	-$2.54M	-$0.02	N/A
Option Care Health	$5.65B	0.61	$207.59M	$1.33	17.25

Option Care Health has a net margin of 3.68% compared to InnovAge's net margin of -0.26%. Option Care Health's return on equity of 18.74% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-0.26%	-1.03%	-0.47%
Option Care Health	3.68%	18.74%	7.25%

Summary

Option Care Health beats InnovAge on 14 of the 16 factors compared between the two stocks.

Get InnovAge News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INNV vs. The Competition

Export

Metric	InnovAge	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.45B	$9.76B	$7.33B	$13.29B
Dividend Yield	N/A	2.59%	2.52%	12.57%
P/E Ratio	-442.00	34.16	274.40	25.75
Price / Sales	1.22	4.96	639.66	87.10
Price / Cash	74.64	122.11	77.80	52.76
Price / Book	5.02	5.19	10.52	6.34
Net Income	-$2.54M	$315.70M	$3.49B	$360.00M
7 Day Performance	-17.38%	-1.94%	-1.08%	-0.11%
1 Month Performance	-19.78%	-2.33%	-3.39%	-3.42%
1 Year Performance	74.70%	12.96%	15.08%	5.46%

InnovAge Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INNV InnovAge	2.2554 of 5 stars	$8.84 -1.8%	$10.50 +18.8%	+87.1%	$1.45B	$989.71M	N/A	2,500	High Trading Volume
RDNT RadNet	3.5258 of 5 stars	$73.93 +1.7%	$90.00 +21.7%	-5.2%	$5.72B	$2.04B	N/A	11,264	Analyst Forecast
BLLN Billiontoone	2.3406 of 5 stars	$116.07 +11.8%	$125.88 +8.4%	N/A	$4.90B	$305.11M	165.81	713	News Coverage Insider Trade
LFST LifeStance Health Group	3.889 of 5 stars	$12.55 -0.9%	$12.88 +2.6%	+125.8%	$4.84B	$1.42B	96.55	10,961
CRVL CorVel	1.6571 of 5 stars	$73.59 +2.5%	N/A	-8.5%	$3.66B	$958.53M	32.71	5,239

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INNV) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InnovAge (INNV) Competitors

INNV vs. RDNT, BLLN, LFST, CRVL, and OPCH

How does InnovAge compare to RadNet?

Summary

How does InnovAge compare to Billiontoone?

Summary

How does InnovAge compare to LifeStance Health Group?

Summary

How does InnovAge compare to CorVel?

Summary

How does InnovAge compare to Option Care Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InnovAge (INNV) Competitors

INNV vs. RDNT, BLLN, LFST, CRVL, and OPCH

How does InnovAge compare to RadNet?

Which has higher valuation & earnings, RDNT or INNV?

Do insiders & institutionals have more ownership in RDNT or INNV?

Do analysts rate RDNT or INNV?

Is RDNT or INNV more profitable?

Does the media refer more to RDNT or INNV?

Which has more volatility and risk, RDNT or INNV?

Summary

How does InnovAge compare to Billiontoone?

Which has higher earnings & valuation, INNV or BLLN?

Do analysts recommend INNV or BLLN?

Is INNV or BLLN more profitable?

Do institutionals & insiders hold more shares of INNV or BLLN?

Does the media refer more to INNV or BLLN?

Summary

How does InnovAge compare to LifeStance Health Group?

Do analysts prefer INNV or LFST?

Which has more volatility & risk, INNV or LFST?

Do institutionals and insiders hold more shares of INNV or LFST?

Is INNV or LFST more profitable?

Which has higher valuation and earnings, INNV or LFST?

Does the media prefer INNV or LFST?

Summary

How does InnovAge compare to CorVel?

Which has better valuation & earnings, CRVL or INNV?

Which has more risk and volatility, CRVL or INNV?

Do insiders and institutionals believe in CRVL or INNV?

Is CRVL or INNV more profitable?

Do analysts rate CRVL or INNV?

Does the media refer more to CRVL or INNV?

Summary

How does InnovAge compare to Option Care Health?

Do insiders & institutionals hold more shares of INNV or OPCH?

Does the media favor INNV or OPCH?

Which has more risk & volatility, INNV or OPCH?

Do analysts rate INNV or OPCH?

Which has stronger valuation & earnings, INNV or OPCH?

Is INNV or OPCH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools